Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Cardio Diagnostics Holdings, Inc. (CDIO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Cardio Diagnostics Holdings, Inc. (CDIO), most recent 12 months reported: revenue $14.45K, net loss $6.47M, free cash flow -$5.82M. Latest balance sheet on file: liquid cash $5.59M. From SEC filings. Others in In Vitro & In Vivo Diagnostic Substances: Anbio Biotechnology · Aspira Women’s Health Inc. · BIOMERICA, INC. · VolitionRx Limited · Insight Molecular Diagnostics Inc. · Celldex Therapeutics, Inc. · Achieve Life Sciences, Inc. · Q/C Technologies, Inc.

Stock screener

Watchlist